The global report for nodular prurigo market is predicted to reveal substantial growth from 2024 to 2025, showing a market worth of $1.17 billion expanding to $1.25 billion.

Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year treatment period, according to long-term extension data presented at the ...

Pulmonary rheumatoid nodules can resemble cancer or infection, making biopsy and careful imaging critical for accurate diagnosis.

ZUG, Switzerland, June 25, 2025--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety ...

In this video, Robert J. Smith, MD, discusses barriers to care in atopic dermatitis.

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that Thomas Dittrich, Chief Financial Officer, will be leaving the c ...

The Many Ways to Measure the Severity of Atopic Dermatitis — Validated physician-reported tools are often complicated, but patient-based measures are easy and informative ...

Subjects in the trial saw clearance or near-clearance of skin nodules, as measured by the Investigator’s Global Assessment score.

J&J agrees to buy Numab subsidiary Yellow Jersey and its NM26 bispecific antibody for atopic dermatitis in a $1.25bn deal.